Uro-Vaxom® now available in Brazil
April 30th, 2008

Meyrin/Geneva. OM PHARMA's partner ASPEN (www.aspen.com.br) has now launched Uro-Vaxom® on the Brazilian market. This oral medication is the first and leading immunological product for the prevention and treatment of recurrent urinary tract infections. It is already marketed in more than 30 countries with a documented high success rate in the management of these infections.

Top of the page